Asensus Surgical Inc. (AMEX:ASXC) currently has a daily average trading volume of 888.07K but it saw 937981 shares traded on Thursday. With a market cap of 123.32M USD, stock’s current market price of $0.52 came falling about -7.42 while comparing to the previous closing price of $0.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.18 and as low as $0.28. In the recent trading on the day, stock has struck highest price mark of $0.57 while lowest mark touched by it was $0.51.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Taking a look at 20-day trading activity of Asensus Surgical Inc. (ASXC) gives us an average price of $0.6072, while its current price level is -56.14% below from 52-week high level whereas it is 84.86% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6443 while that of 200 days or SMA-200 reads an average of $0.5639. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.24% during that period while stretching the period over a month that decreases to 7.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 29.51 which implies that the stock is in oversold territory.
Asensus Surgical Inc. (ASXC)’s stock is currently under the radar of 2 analysts who are in consensus at a 12-month price target range of between $1.30 and $2.00 for company’s shares. The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $1.30 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $2.00. Average price target assigned by them is $1.65 which highlights an upside potential of 68.48% for the stock over that period. And to attain the median price target of $1.65 assigned by those analysts, stock has to add about 68.48% of value to its current levels.
Data by FactSet Research shows that 2 analysts have issued their ratings for the stock. 0 of them are in opinions that stock is a Sell, while 0 are advising it as an Overweight. 2 analysts suggested the investors to Buy the stock while 0 advised them to Hold. Recommendations by all of those brokerages imply a consensus rating of Buy for the stock and that issued by Wall Street to investors is Moderate Buy.
Over the week, ASXC’s stock price is moving -9.54% down while it is -20.27% when we observe its performance for the past one month. Year-to-date it is 49.12% up and over the past year, the stock is showing an upside performance of 34.86%.
The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of -$0.09 beaten by the consensus estimate of -$0.08 for the same. The company is expected to be releasing its next quarterly report in 08/09/2023, for which analysts forecasted an EPS of -$0.08 while estimate for next year EPS is -$0.32. In next quarter, company is expected to be making quarterly sales of $1.99 million as analysts are expecting the sales for current fiscal year at $8.66 million and seeing the company making $16.56 million in sales next year. Moreover, analysts are in estimates of $1.07 million for current-quarter revenue.
Currently, Asensus Surgical Inc.’s total number of outstanding shares is 238.28M with 1.15% of that held by the insiders while 10.84% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -76.30% and return on equity (ROE) at -74.20%. Stock’s beta reads 1.72. Stock has a price to book (P/B) ratio of 1.57 while price to sale or P/S ratio amounts to 17.62. Its return on asset (ROA) is -64.40% on average.
Leave a Reply